Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant
Public ClinicalTrials.gov record NCT00361049. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Donor Mesenchymal Stem Cell Infusion for Treatment of Graft Versus Host Disease: A Phase I Trial
Study identification
- NCT ID
- NCT00361049
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Case Comprehensive Cancer Center
- Other
- Enrollment
- 49 participants
Conditions and interventions
Conditions
Interventions
- fluorescence in situ hybridization Genetic
- graft versus host disease prophylaxis/therapy Biological
- immunoenzyme technique Other
- immunohistochemistry staining method Other
- in vitro-treated bone marrow transplantation Procedure
- laboratory biomarker analysis Other
- management of therapy complications Procedure
Genetic · Biological · Other + 1 more
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2004
- Primary completion
- May 31, 2009
- Completion
- Oct 31, 2010
- Last update posted
- Nov 4, 2010
2004 – 2010
United States locations
- U.S. sites
- 8
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Geauga Regional Hospital | Cleveland | Ohio | 44024 | — |
| Lake/University Ireland Cancer Center | Cleveland | Ohio | 44060 | — |
| Ireland Cancer Center at University Hosptials Case Medical Center, Case Comprehensive Cancer Center | Cleveland | Ohio | 44106-5065 | — |
| University Suburban Health Center | Cleveland | Ohio | 44121 | — |
| UHHS Chagrin Highlands Medical Center | Cleveland | Ohio | 44122 | — |
| Southwest General Health Center | Cleveland | Ohio | 44130 | — |
| UHHS Westlake Medical Center | Cleveland | Ohio | 44145 | — |
| Mercy Cancer Center at Mercy Medical Center | Cleveland | Ohio | 44708 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00361049, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 4, 2010 · Synced May 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00361049 live on ClinicalTrials.gov.